These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10083311)

  • 1. Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response.
    Maggard MA; Johnson C; Wang T; Terasaki P; Kupiec-Weglinski JW; Busuttil RW; Imagawa DK
    Transplant Proc; 1999; 31(1-2):728-9. PubMed ID: 10083311
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
    Poston RS; Billingham M; Hoyt EG; Pollard J; Shorthouse R; Morris RE; Robbins RC
    Circulation; 1999 Jul; 100(1):67-74. PubMed ID: 10393683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of 15-deoxyspergualin on coronary arteriosclerosis in the transplanted heart.
    Hachida M; Zhang X; Lu H; Hoshi H; Koyanagi H
    Transplant Proc; 1999; 31(1-2):143-6. PubMed ID: 10083050
    [No Abstract]   [Full Text] [Related]  

  • 4. Induction therapy with an immunomodulatory CD2 antibody does not inhibit allograft vasculopathy after rat heart transplantation.
    Dengler TJ; Szabo G; Amann K; Nottmeyer W; Vahl C; Hagl S; Zimmermann R
    Transplant Proc; 1998 May; 30(3):868-70. PubMed ID: 9595130
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor treatment prolongs survival of rat cardiac allografts in sensitized rat recipients.
    Schmidbauer G; Kuenzel JS; Homeyer A; Schwemmle K
    Transplant Proc; 2002 Nov; 34(7):2897-8. PubMed ID: 12431650
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats.
    Hisatomi K
    Transplant Proc; 1998 Dec; 30(8):4337-9. PubMed ID: 9865378
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of heart/kidney versus double heart transplantation on tolerance induction and prevention of cardiac allograft vasculopathy.
    Yamada K; Menard MT; Mawulawde K; Slisz JK; Choo JK; Erhorn AE; Sachs DH; Madsen JC
    Transplant Proc; 1999; 31(1-2):108. PubMed ID: 10083032
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytokine and alloantibody networks in long-term cardiac allografts in rapamycin-treated sensitized rat recipients.
    Wasowska B; Wieder KJ; Hancock WW; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):423-6. PubMed ID: 7879047
    [No Abstract]   [Full Text] [Related]  

  • 10. No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
    Ito H; Hamano K; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K
    Transplant Proc; 1996 Jun; 28(3):1823. PubMed ID: 8658900
    [No Abstract]   [Full Text] [Related]  

  • 11. TCV-116 reduces chronic rejection in a rat heterotopic cardiac transplant model.
    Richter M; Westphal M; Maybaum B; Richter H; Skupin M; Mohr FW; Olbrich HG
    Transplant Proc; 1999; 31(1-2):106-7. PubMed ID: 10083031
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity.
    Korom S; De Meester I; Schmidbauer G; Pratschke J; Brendel MD; Durinx C; Schwemmle K; Haemers A; Scharpé S; Kupiec-Weglinski JW
    Transplant Proc; 1999; 31(1-2):778. PubMed ID: 10083329
    [No Abstract]   [Full Text] [Related]  

  • 13. Function of inflammatory cells and neoral cyclosporin-A in heart transplant-associated coronary vasculopathy.
    Buján J; Jurado F; Gimeno MJ; Rodriguez M; Bellón JM
    Histol Histopathol; 2001 Jan; 16(1):197-203. PubMed ID: 11193195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model.
    Richter MH; Richter H; Barten M; Schramm D; Weinert M; Gummert J; Mohr FW; Olbrich HG
    Transplant Proc; 2002 Aug; 34(5):1479-80. PubMed ID: 12176448
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
    Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
    [No Abstract]   [Full Text] [Related]  

  • 16. Abrogation of accelerated allograft rejection by intrathymic injection of donor spleen cells is associated with upregulation of donor-reactive IgM, IgG1, and IgG2A, but depression of IgG2B in the circulation and at the graft site.
    Binder J; Hancock WW; Watschinger B; Wasowska B; Sayegh MH; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):138-41. PubMed ID: 7878919
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Tranilast on chronic graft vascular disease and tracheal proliferation in a rat allograft model.
    Teranishi K; Usui A; Maseki T; Watanabe T; Yasuura K; Imaizumi M
    Transplant Proc; 1999 Nov; 31(7):2772-4. PubMed ID: 10578286
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G; Hancock WW; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):427-9. PubMed ID: 7879048
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effect of triptolide on platelet derived growth factor-A and coronary arteriosclerosis after heart transplantation.
    Hachida M; Lu H; Zhang X; Saito S; Furutani Y; Matsuoka R; Hoshi H; Koyanagi H
    Transplant Proc; 1999 Nov; 31(7):2719-23. PubMed ID: 10578264
    [No Abstract]   [Full Text] [Related]  

  • 20. Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog.
    Wahlers T; Mügge A; Oppelt P; Heublein B; Fieguth HG; Jurmann M; Haverich A
    Transplant Proc; 1994 Oct; 26(5):2741-2. PubMed ID: 7940860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.